BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 9622728)

  • 1. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytological screening history of patients with early invasive cervical cancer.
    Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
    Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and adenocarcinoma of the cervix.
    Sasieni P; Castanon A; Cuzick J
    Int J Cancer; 2009 Aug; 125(3):525-9. PubMed ID: 19449379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
    Smrkolj S; Rakar S; Mozina A; Erzen M
    Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of adenocarcinoma of the uterine cervix in mass cytological and colposcopic diagnostic studies].
    Pieroni G; Cariaggi P; Ottaviano M; Marchionni M; Mincione G; Bartoloni St Omer F
    Minerva Ginecol; 1975 May; 27(5):418-21. PubMed ID: 1134695
    [No Abstract]   [Full Text] [Related]  

  • 6. [How technology and vaccination have changed the Pap test].
    Bondi A; Ghidoni D; Amadori A
    Pathologica; 1999 Feb; 91(1):36-41. PubMed ID: 10396949
    [No Abstract]   [Full Text] [Related]  

  • 7. The changing pattern of cervical cancer in Northern Ireland 1965-1989.
    Robertson JH; Woodend B
    Ulster Med J; 1992 Apr; 61(1):19-23. PubMed ID: 1621297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer: prevention and treatment.
    Denny L
    Discov Med; 2012 Aug; 14(75):125-31. PubMed ID: 22935209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening in north-east Scotland.
    Macgregor JE; Moss S; Parkin DM; Day NE
    IARC Sci Publ; 1986; (76):25-36. PubMed ID: 3570409
    [No Abstract]   [Full Text] [Related]  

  • 11. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
    Castanon A; Landy R; Sasieni PD
    Int J Cancer; 2016 Sep; 139(5):1040-5. PubMed ID: 27096255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening: patients understanding in major hospitals in Malaysia.
    Othman NH; Devi BC; Halimah Y
    Asian Pac J Cancer Prev; 2009; 10(4):569-74. PubMed ID: 19827871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results from a cervical cancer screening programme in Manitoba, Canada.
    Choi NW; Nelson NA
    IARC Sci Publ; 1986; (76):61-7. PubMed ID: 3570416
    [No Abstract]   [Full Text] [Related]  

  • 15. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical carcinoma in Nigeria--a need for early detection.
    Edozien LC; Adewole IF
    Afr J Med Med Sci; 1993 Dec; 22(4):87-92. PubMed ID: 7839937
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytological diagnosis of cancer of the uterine cervix. Results during 1971].
    Gerber E; Vajda D
    Rev Med Suisse Romande; 1972 Oct; 92(10):813-28. PubMed ID: 4660894
    [No Abstract]   [Full Text] [Related]  

  • 18. Rare endocervical tumour may be a diagnostic dilemma on Papanicolaou smear.
    Kumar Y; Bhutani A; Sharma S
    Diagn Cytopathol; 2011 Jul; 39(7):505-7. PubMed ID: 20949452
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytological mass screening in Ostfold County, Norway.
    Magnus K; Langmark F
    IARC Sci Publ; 1986; (76):87-90. PubMed ID: 3570418
    [No Abstract]   [Full Text] [Related]  

  • 20. Mass cervical cancer screening program by irrigation smear in Japan.
    Kawashima Y; Ino S; Tashiro K; Tachibana M; Masukawa T
    Obstet Gynecol; 1968 Jul; 32(1):17-23. PubMed ID: 5742086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.